QL9 (QLSPFPFDL) is a high-affinity alloantigen for the 2C T cell receptor (TCR).
QL9 is a synthetic peptide that has garnered significant attention in immunological and biochemical research due to its well-defined sequence and its pivotal role as a model antigenic peptide. Structurally, QL9 is derived from the murine minor histocompatibility antigen and is frequently employed in studies investigating T cell recognition, antigen processing, and major histocompatibility complex (MHC) interactions. As a peptide ligand, it serves as a robust tool for dissecting the molecular mechanisms underlying immune surveillance and T cell activation, making it an essential reagent for fundamental and applied immunology laboratories. Its defined amino acid composition and established immunogenic properties position it as a valuable asset in experimental systems that require precise control over peptide-MHC interactions.
Antigen Presentation Studies: QL9 is extensively utilized in research focused on antigen processing and presentation, particularly within the context of MHC class I molecules. By serving as a model peptide, it enables the detailed characterization of how peptides are loaded onto MHC molecules and subsequently recognized by cytotoxic T lymphocytes (CTLs). This application is critical for unraveling the molecular determinants that govern immune recognition and for mapping the peptide-binding motifs of various MHC alleles, providing insight into the specificity and diversity of immune responses.
T Cell Receptor (TCR) Specificity Analysis: The peptide is a cornerstone in studies aimed at elucidating the structural and functional basis of T cell receptor recognition. Researchers utilize QL9 to probe the fine specificity of TCRs, allowing for the identification of key contact residues and the influence of peptide sequence variations on T cell activation. These investigations are instrumental in advancing the understanding of T cell-mediated immunity and in the rational design of TCR-engineered cellular models for research purposes.
Peptide-MHC Tetramer Generation: In flow cytometry and cellular immunology, QL9 is frequently incorporated into MHC tetramers to facilitate the detection and quantification of antigen-specific T cells. The use of such peptide-loaded tetramers enables high-resolution analysis of T cell populations, supporting studies of immune repertoire diversity, clonal expansion, and antigen-specific immune monitoring in both basic and translational research settings.
Structural Biology and Biophysical Characterization: QL9 serves as an ideal candidate for crystallography, NMR spectroscopy, and other biophysical methods aimed at resolving the structures of peptide-MHC and peptide-MHC-TCR complexes. Its use in structural studies provides atomic-level insights into the interactions that drive antigen recognition, informing models of immune specificity and the development of molecular tools for immunological research.
Peptide-Based Assay Development: The defined sequence and immunological relevance of QL9 make it a valuable standard in the development and validation of peptide-based assays. It is employed as a reference substrate in enzyme assays, binding studies, and functional screening platforms designed to evaluate peptide-MHC interactions, proteasomal processing, or T cell activation thresholds. The reproducibility and well-characterized nature of this peptide support its role as a benchmark in assay optimization and comparative analyses across diverse experimental systems.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More